Manufacturer record
Pharmaroots Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Pharmaroots Healthcare (Himachal Pradesh) were declared Not of Standard Quality between September 2023 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PC-40473, Enteric Coated Rabeprazole Sodium & Domperiodne Sustained Release Capluses (exp Sep 2026). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Content for Rabeprazole Sodium & Dissolution for Rabeprazole sodium & Domperidone. Listed in the August 2026 alert.
Records by type
16 records linked to Pharmaroots Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Enteric Coated Rabeprazole Sodium & Domperiodne Sustained Release Capluses | Batch PC-40473Mfg Oct 2024 · Exp Sep 2026 | Content for Rabeprazole Sodium & Dissolution for Rabeprazole sodium & DomperidoneDissolution | SDT&RL, BhubaneswarState lab | Aug 2026 |
| Clopidogrel & Aspirin Tablets IP | Batch P0825176TMfg Aug 2025 · Exp Jul 2027 | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Ramipril Tablets IP 2.5 MG | Batch PT-51725Mfg May 2025 · Exp Apr 2027 | The sample does not conform to claim as per IP 2022 in respect to the test of Dissolution and Assay of RamiprilAssay | RDTL, ChandigarhCDSCO lab | Mar 2026 |
| Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Oral Suspension IP | Batch PL-40143Mfg Jun 2024 · Exp May 2026 | Content and Microbial LimitMicrobial limits | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Telmisartan Tablets IP 40mg Savtel 40 Tablets | Batch PT- 40584Mfg Feb 2024 · Exp Jan 2026 | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Telmisartan.Dissolution | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Ramipril Tablets IP 2.5 mg | Batch PT-44206Mfg Dec 2024 · Exp Nov 2026 | Test for Dissolution & Assay for RAmiprilAssay | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Savtel Telmisartan Tablets IP 40 mg. | Batch PT-40585Mfg Feb 2024 · Exp Jan 2026 | sample does not conform to claim as per I.P. 2022 in respect to the Test of DissolutionDissolution | RDTL, GuwahatiCDSCO lab | Sep 2025 |
| Telmisartan Tablets IP 40mg (Savtel 40 Tablets) | Batch PT-40586Mfg Feb 2024 · Exp Jan 2026 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40mg (Savtel 40 Tablets) | Batch PT-40584Mfg Feb 2024 · Exp Jan 2026 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
| Isosorbide Dinitrate Tablets IP [ISOMIC 10] | Batch PT- 42968Mfg Aug 2024 · Exp Jul 2026 | The sample does not conform to identification test for Isosorbide Dinitrate as per IP. Hence the sample is spurious and declared as Not of Standard QualityIdentification | DTL ThiruvananthapuramState lab | Feb 2025 |
| CALCIUM CARBONATE TABLETS IP 500 mg. | Batch PT-30670Mfg Apr 2023 · Exp Mar 2025 | DisintegrationDisintegration | RDTL GuwahatiState lab | Mar 2024 |
| CALCIUM CARBONATE TABLETS IP 500 mg. | Batch PT-30665Mfg Apr 2023 · Exp Mar 2025 | MisbrandedMisbranded | RDTL GuwahatiState lab | Mar 2024 |
| TESCALVIT D3 Tablets (Calcium Carbonate & Vitamin D3 Tablets) | Batch PT-30296Mfg Feb 2023 · Exp Jan 2025 | Assay of Vitamin D3 and DescriptionAssay | CDL KolkataCDSCO lab | Dec 2023 |
| Glimepiride Tablets IP.. (Glimnol-1 Tablets) | Batch PT-22953Mfg Jan 2023 · Exp Dec 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2023 |
| AMLODIPINE BESYLATE TABLETS I.P. 5 mg. (AMLOMART-5 mg TABLETS) | Batch PT-31011Mfg Apr 2023 · Exp Mar 2025 | Assay of AmlodipineAssay | RDTL GuwahatiState lab | Oct 2023 |
| CALCIUM CARBONATE TABLETS IP 500 mg. | Batch PT-30625Mfg Apr 2023 · Exp Mar 2025 | Disintergrati onOther | RDTL GuwahatiState lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.